EGFRvIII-targeted metabolically armed CAR-T cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EGFRvIII-targeted metabolically armed CAR-T cell therapy, covering 2025-11-24 to 2025-11-24. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Preliminary Efficacy of a Metabolically Armed Chimeric Antigen Receptor T Cell Therapy Targeting EGFRvIII for Recurrent Glioblastoma [EARLY_Phase 1]